The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.
Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
92 | 99 | 96 | 91 |
Growth
|
21 | 1 | 11 | 23 |
Safety
|
93 | 100 | 96 | 94 |
Sentiment
|
1 | 8 | 12 | 11 |
|
58 | 61 | 61 | 57 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Analyst Opinions
|
9 | 5 | 12 | 5 |
Opinions Change
|
2 | 50 | 50 | 50 |
Pro Holdings
|
n/a | 30 | 12 | 55 |
Market Pulse
|
23 | 34 | 40 | 28 |
Sentiment
|
1 | 8 | 12 | 11 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
92 | 99 | 96 | 91 |
Growth
|
21 | 1 | 11 | 23 |
|
93 | 100 | 96 | 94 |
Combined
|
98 | 98 | 90 | 91 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Price vs. Sales (P/S)
|
72 | 100 | 95 | 76 |
Price vs. Earnings (P/E)
|
81 | 80 | 75 | 81 |
Price vs. Book (P/B)
|
97 | 97 | 92 | 96 |
Dividend Yield
|
1 | 1 | 1 | 1 |
Value
|
92 | 99 | 96 | 91 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Revenue Growth
|
6 | 21 | 20 | 20 |
Profit Growth
|
100 | 19 | 18 | 72 |
Capital Growth
|
5 | 12 | 58 | 23 |
Stock Returns
|
19 | 31 | 37 | 33 |
Growth
|
21 | 1 | 11 | 23 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Leverage
|
68 | 82 | 60 | 66 |
Refinancing
|
73 | 72 | 71 | 53 |
Liquidity
|
64 | 71 | 77 | 66 |
|
93 | 100 | 96 | 94 |
Discover high‑ranked alternatives to Avanos Medical and broaden your portfolio horizons.
The Obermatt Advantage
Choose the Obermatt subscription that best fits your needs.